Senthil K. Selvaraj

Senthil K. Selvaraj

Advanced Heart Failure and Transplant Cardiology | Cardiology

40 Duke Medicine Cir
Durham, NC 27710

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 118 publications

Targeted Therapy for ATTR-CM Amidst a Rapidly Evolving Landscape: A Moving Goalpost?

Targeted Therapy for ATTR-CM Amidst a Rapidly Evolving Landscape: A Moving Goalpost?

Journal: Journal of the American College of Cardiology

Published: July 30, 2026

Calcium Channel Blockade Versus β-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial.

Calcium Channel Blockade Versus β-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: May 15, 2026

Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.

Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.

Journal: Heart failure reviews

Published: March 19, 2026

Outpatient clinic visits before and after hospitalizations for heart failure with and without transthyretin amyloid cardiomyopathy.

Outpatient clinic visits before and after hospitalizations for heart failure with and without transthyretin amyloid cardiomyopathy.

Journal: European journal of heart failure

Published: March 03, 2026

Feasibility and acceptability of remote ischemic conditioning combined with low-intensity resistance training in older adults with mobility impairments: A randomized controlled pilot trial protocol.

Feasibility and acceptability of remote ischemic conditioning combined with low-intensity resistance training in older adults with mobility impairments: A randomized controlled pilot trial protocol.

Journal: Experimental gerontology

Published: January 15, 2026

Transthyretin amyloid depletion therapy: lessons from the phase 2 trial of coramitug.

Transthyretin amyloid depletion therapy: lessons from the phase 2 trial of coramitug.

Journal: Heart failure reviews

Published: December 22, 2025

From Fuel to Flow: Translating the Beneficial Hemodynamic Effects of Exogenous Ketones in the ICU.

From Fuel to Flow: Translating the Beneficial Hemodynamic Effects of Exogenous Ketones in the ICU.

Journal: JACC. Heart failure

Published: December 22, 2025

Clinical Outcomes and Health Care Costs in Patients Hospitalized With Heart Failure and Transthyretin Amyloid Cardiomyopathy: Findings From GWTG-HF.

Clinical Outcomes and Health Care Costs in Patients Hospitalized With Heart Failure and Transthyretin Amyloid Cardiomyopathy: Findings From GWTG-HF.

Journal: Journal of cardiac failure

Published: September 22, 2025

Therapeutic Implications of ErbB Pathway Modification in Heart Failure with Reduced Ejection Fraction.

Therapeutic Implications of ErbB Pathway Modification in Heart Failure with Reduced Ejection Fraction.

Journal: JACC. Basic to translational science

Published: July 16, 2025

Late-Life Echocardiographic Effects of the Amyloidogenic p.V142I Transthyretin Variant.

Late-Life Echocardiographic Effects of the Amyloidogenic p.V142I Transthyretin Variant.

Journal: Circulation. Heart failure

Published: May 18, 2025

Serum Transthyretin as a Biomarker of Treatment Response in ATTR Cardiomyopathy.

Serum Transthyretin as a Biomarker of Treatment Response in ATTR Cardiomyopathy.

Journal: Journal of the American College of Cardiology

Published: March 21, 2025

Crossover Trial of Exogenous Ketones on Cardiometabolic Endpoints in Heart Failure With Preserved Ejection Fraction.

Crossover Trial of Exogenous Ketones on Cardiometabolic Endpoints in Heart Failure With Preserved Ejection Fraction.

Journal: JACC. Heart failure

Published: February 15, 2025

Showing 1-12 of 118

Last Updated: 09/26/2026